Hepatitis B
612
30
42
409
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
142 trials with published results (23%)
Research Maturity
409 completed trials (67% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.2%
38 terminated out of 612 trials
91.5%
+5.0% vs benchmark
38%
233 trials in Phase 3/4
35%
142 of 409 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 409 completed trials
Clinical Trials (612)
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
Evaluation of Patients With Liver Disease
Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)
A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)
Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria
Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection
A Real-world Study: Analysis of the Efficacy of Antiviral Therapy in CHB Patients Over 30 Years Old, HBV DNA Positive and ALT Normal
Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV
Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure.
A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease
Real World Assessment of People Living With Chronic Hepatitis B in Australia
Hep Mec Cohort in Zambia
Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers